RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret Balance Sheet Health
Financial Health criteria checks 3/6
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret has a total shareholder equity of TRY1.5B and total debt of TRY171.1M, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are TRY1.7B and TRY200.3M respectively.
Key information
11.1%
Debt to equity ratio
₺171.06m
Debt
| Interest coverage ratio | n/a |
| Cash | ₺13.66m |
| Equity | ₺1.55b |
| Total liabilities | ₺200.29m |
| Total assets | ₺1.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RTALB's short term assets (TRY184.4M) exceed its short term liabilities (TRY161.8M).
Long Term Liabilities: RTALB's short term assets (TRY184.4M) exceed its long term liabilities (TRY38.5M).
Debt to Equity History and Analysis
Debt Level: RTALB's net debt to equity ratio (10.2%) is considered satisfactory.
Reducing Debt: RTALB's debt to equity ratio has increased from 0.1% to 11.1% over the past 5 years.
Debt Coverage: RTALB's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if RTALB's interest payments on its debt are well covered by EBIT.